Bimzelx 320 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB26FX4NA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,208
Award facts
- Contract value 100% obligated
- $72,208.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $72,208.24 on November 7, 2025, for the supply of BIMZELX 320 mg/2 mL auto-injector units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 10, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems.
This delivery order falls within AmerisourceBergen's established role as a prime vendor for the DLA Medical Supply Chain, which encompasses a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. BIMZELX is a specialty pharmaceutical product typically used for immunological conditions, reflecting the company's capability to deliver specialized medications in addition to brand-name and generic drugs, vaccines, and medical devices. The rapid completion timeline of three days suggests this represents an urgent medical supply requirement for Defense Health Agency customers or other government healthcare systems supported through the DLA's global pharmaceutical support network.
Quick answers
Who was awarded contract SPE2DB26FX4NA?
SPE2DB26FX4NA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FX4NA worth?
The government has obligated $72,208 on SPE2DB26FX4NA.
Is contract SPE2DB26FX4NA an order under another contract?
Yes. SPE2DB26FX4NA is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4NA competed?
The extent of competition for SPE2DB26FX4NA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award